Mycronic AB (publ) (MYCR.ST)
SEK 413.0
(2.74%)
SEK 413.0
(2.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.6 Billion | 853 Million | 998 Million | 1.12 Billion | 545 Million | 702.37 Million |
| Net Income | 998 Million | 890 Million | 1.04 Billion | 890 Million | 1.12 Billion | 1.01 Billion |
| Depreciation & Amortization | 222 Million | 253 Million | 205 Million | 214 Million | 182 Million | 73.88 Million |
| Deferred income taxes | -724.3 Million | - | - | - | - | - |
| Stock-based compensation | 3.3 Million | - | - | - | - | - |
| Change in working capital | 138 Million | -113 Million | -68 Million | 218 Million | -497 Million | -225.21 Million |
| Other non-cash items | 971 Million | -177 Million | -185 Million | -196 Million | -262 Million | -157.39 Million |
| Investing Cash Flow | -195 Million | 67 Million | -1.22 Billion | -150 Million | -399 Million | -440.48 Million |
| Investments in PPE | -194 Million | -141 Million | -90 Million | -135 Million | -152 Million | -68.76 Million |
| Acquisitions | -5 Million | 216 Million | -1.11 Billion | -4 Million | -248 Million | -367.43 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4 Million | -8 Million | -16 Million | -11 Million | 1 Million | -4.28 Million |
| Financing Cash Flow | -447 Million | -382 Million | -437 Million | -288 Million | -326 Million | -258.22 Million |
| Debt repayment | -88 Million | -84 Million | -83 Million | -76 Million | -54 Million | -13.43 Million |
| Dividends payments | -342 Million | -294 Million | -294 Million | -196 Million | -294 Million | -244.79 Million |
| Common Stock Repurchased | -26 Million | -16 Million | -23 Million | -15 Million | -21 Million | - |
| Common Stock Issuance | - | 5 Million | 10 Million | - | - | - |
| Other Financing Activities | 9 Million | 7 Million | -47 Million | -1 Million | 43 Million | - |
| Accounts receivables | -136 Million | -435 Million | 54 Million | 176 Million | -126 Million | -176.55 Million |
| Accounts payables | 94 Million | -2 Million | -1 Million | -15 Million | 53 Million | 73.52 Million |
| Inventory | -235 Million | -26 Million | -26 Million | -213 Million | -237 Million | -196.63 Million |
| Other working capital | 415 Million | 350 Million | -95 Million | 270 Million | -187 Million | -28.58 Million |
| Cash at beginning of period | 1.27 Billion | 692 Million | 1.3 Billion | 655 Million | 829 Million | 812.66 Million |
| Cash at end of period | 2.14 Billion | 1.27 Billion | 683 Million | 1.3 Billion | 655 Million | 828.57 Million |
| Capital Expenditure | -194 Million | -141 Million | -90 Million | -135 Million | -152 Million | -68.76 Million |
| Effect of forex changes on cash | -100 Million | 44 Million | 51 Million | -41 Million | 6 Million | 12.23 Million |
| Net cash flow / Change in cash | 866 Million | 582 Million | -620 Million | 648 Million | -174 Million | 15.9 Million |
| Free Cash Flow | 1.41 Billion | 712 Million | 908 Million | 991 Million | 393 Million | 633.6 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 560 Million | 287 Million | 488 Million | 998 Million | 510 Million | 268 Million |
| Depreciation & Amortization | - | 10 Million | 61 Million | 222 Million | -55 Million | 67 Million |
| Deferred income taxes | - | - | - | -724.3 Million | 51.7 Million | - |
| Stock-based compensation | - | - | - | 3.3 Million | 3.3 Million | - |
| Change in working capital | -514 Million | -12 Million | 127 Million | 138 Million | -185 Million | -103 Million |
| Other non-cash items | 52 Million | 97 Million | 61 Million | 971 Million | 237 Million | -20 Million |
| Investing Cash Flow | -44 Million | -213 Million | -49 Million | -195 Million | -55 Million | -54 Million |
| Investments in PPE | - | -32 Million | -36 Million | -194 Million | -10 Million | -39 Million |
| Acquisitions | - | - | - | -5 Million | -6 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -44 Million | -181 Million | -13 Million | 4 Million | -39 Million | -15 Million |
| Financing Cash Flow | -44 Million | -462 Million | -26 Million | -447 Million | -16 Million | -40 Million |
| Debt repayment | - | - | - | -88 Million | - | - |
| Dividends payments | - | - | - | -342 Million | - | - |
| Common Stock Repurchased | - | - | - | -26 Million | -9 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -44 Million | -462 Million | -26 Million | 9 Million | -7 Million | -40 Million |
| Accounts receivables | - | - | - | -136 Million | -210 Million | - |
| Accounts payables | - | - | - | 94 Million | 94 Million | - |
| Inventory | - | - | - | -235 Million | -235 Million | - |
| Other working capital | -514 Million | -12 Million | 127 Million | 415 Million | 166 Million | -103 Million |
| Cash at beginning of period | 2.53 Billion | 2.84 Billion | 2.14 Billion | 1.27 Billion | 1.74 Billion | 1.63 Billion |
| Cash at end of period | 2.53 Billion | 2.53 Billion | 2.84 Billion | 2.14 Billion | 2.14 Billion | 1.74 Billion |
| Capital Expenditure | - | -32 Million | -36 Million | -194 Million | -10 Million | -39 Million |
| Effect of forex changes on cash | -13 Million | -13 Million | 40 Million | -100 Million | -96 Million | -6 Million |
| Net cash flow / Change in cash | -3 Million | -306 Million | 701 Million | 866 Million | 395 Million | 113 Million |
| Free Cash Flow | 98 Million | 350 Million | 701 Million | 1.41 Billion | 552 Million | 173 Million |
0HI3
FF
601615
GEKTERNA
NWBO
002942